Nirman Agri Genetics Limited — Important, 06-02-2025: Financial Result Updates

Revenue for the quarter ended December 31, 2024, stands at ₹61.07 crore, reflecting a growth of approximately 21.3% compared to ₹50.35 crore in the same quarter last year. This growth can be attributed to increased demand driven by market expansion efforts and possibly improved operational efficiencies.

Net profit for the quarter is reported at ₹6.73 crore, up from ₹5.04 crore in the previous year, yielding an Earnings Per Share (EPS) of ₹8.40, compared to ₹8.45 last year. The improvement in profitability is largely due to effective cost management, although operational costs have increased marginally.

Total expenses for the quarter were ₹54.22 crore, representing a 16.6% rise from the previous year’s ₹45.12 crore. Employee benefit expenses saw a slight increase, suggesting an expansion in workforce or salary adjustments, yet the overall cost management strategy appears sound as the company maintains profitability.

The balance sheet remains robust, with a paid-up share capital of ₹8.01 crore. The outlook appears positive, driven by a strategic focus on market penetration and operational efficiencies. Overall, based on these financial results and growth trends, a hold insight is warranted, with attention to ongoing cost management and market conditions moving forward.